Novo Nordisk faces FDA scrutiny over unreported Ozempic side effects, including deaths and a suicide, amid struggles to compete with Eli Lilly in the US obesity drug market. Despite risks like nausea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results